Michael Möhlen

Title: Michael Möhlen: Innovator in Vaccine Development

Introduction

Michael Möhlen is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of vaccine development, holding a total of six patents. His work focuses on innovative solutions to combat viral infections, particularly in the context of public health.

Latest Patents

Among his latest patents is the "CpG-adjuvanted SARS-CoV-2 virus vaccine." This invention describes CpG-adjuvanted SARS-CoV-2 vaccines, along with the compositions and methods for producing and administering these vaccines to individuals in need. Another notable patent is related to "Aluminum compounds for use in therapeutics and vaccines." This invention outlines methods for preparing aqueous compositions that contain aluminum and a protein, ensuring that these compositions have minimal heavy metal content.

Career Highlights

Michael Möhlen has worked with notable companies in the biotechnology sector, including Valneva Austria GmbH and Dynavax Technologies Corporation. His experience in these organizations has allowed him to contribute to the advancement of vaccine technologies and therapeutic solutions.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues, including Robert Schlegl and Michael Weber. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Michael Möhlen's work in vaccine development exemplifies the impact of innovative thinking in addressing global health challenges. His contributions continue to shape the future of therapeutics and vaccines.